- Home
- FF vs KOD Comparison
FF vs KOD Comparison
Compare FF & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- KOD
- Stock Information
- Founded
- FF N/A
- KOD 2009
- Country
- FF United States
- KOD United States
- Employees
- FF N/A
- KOD N/A
- Industry
- FF Major Chemicals
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FF Industrials
- KOD Health Care
- Exchange
- FF Nasdaq
- KOD Nasdaq
- Market Cap
- FF 174.8M
- KOD 188.9M
- IPO Year
- FF N/A
- KOD 2018
- Fundamental
- Price
- FF $4.06
- KOD $3.62
- Analyst Decision
- FF
- KOD Hold
- Analyst Count
- FF 0
- KOD 3
- Target Price
- FF N/A
- KOD $9.00
- AVG Volume (30 Days)
- FF 274.1K
- KOD 294.1K
- Earning Date
- FF 08-08-2025
- KOD 08-13-2025
- Dividend Yield
- FF 5.83%
- KOD N/A
- EPS Growth
- FF N/A
- KOD N/A
- EPS
- FF N/A
- KOD N/A
- Revenue
- FF $202,596,000.00
- KOD N/A
- Revenue This Year
- FF N/A
- KOD N/A
- Revenue Next Year
- FF N/A
- KOD N/A
- P/E Ratio
- FF N/A
- KOD N/A
- Revenue Growth
- FF N/A
- KOD N/A
- 52 Week Low
- FF $3.77
- KOD $1.92
- 52 Week High
- FF $6.40
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- FF 50.80
- KOD 46.82
- Support Level
- FF $3.86
- KOD $3.52
- Resistance Level
- FF $4.41
- KOD $3.78
- Average True Range (ATR)
- FF 0.14
- KOD 0.35
- MACD
- FF 0.03
- KOD -0.05
- Stochastic Oscillator
- FF 37.50
- KOD 30.77
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.